Lisburn medtech firm to create 50 new jobs with £1.5m funding

  • Photo: David McCurley, Director, Head of Investments Growth Finance Fund & Dr Hugh Cormican, CEO of Cirdan.

    Lisburn medtech company Cirdan Imaging Ltd will create 50 jobs over the next three years thanks to a £1.5m funding boost from the £30m Growth Finance Fund.

    It is also moving to a new office at the former Coca-Cola factory in Lambeg, which will be able to accommodate up to 150 staff.

    The firm was founded in 2010 and specialises in technology that supports and speeds up diagnosis, primarily used by those working in pathology. The company’s main products are ‘ULTRA’ a Laboratory Information System (LIS) which supports and streamlines the operations of a clinical laboratory and CoreLite, an x-ray system that helps expedite breast cancer diagnosis.

    Dr Hugh Cormican, CEO of Cirdan said the business has “recently signed a new deal with a US distributor for our Corelite product and won a new multimillion-dollar LIS contract supporting laboratories in Singapore and Malaysia, which are exciting new developments for the company.

    RELATED: Cirdan wins major new contract in Australia

    “The objective over the next 18 months is to grow our footprint in the US, Oceania and EMEA markets. Our new production facility will enable us to enhance the product offering we can provide to customers in these key target markets.”

    David McCurley, Director, Head of Investments at the Growth Finance Fund added that “early stage diagnosis of health conditions is a global issue as populations get older. The innovative work undertaken by Cirdan will ensure medical professionals have the most up to date tools available to better treat patients.”

    Finance for the Growth Finance Fund has been provided by the British Business Bank, Invest Northern Ireland and private investors, Northern Ireland Local Government Officers’ Superannuation Committee (NILGOSC). It provides loans from £500,000 up to £2m to established high growth potential SMEs in Northern Ireland.

    RELATED: Belfast medtech Neurovalens chosen for UK start-up scheme

    About the author

    Niamh is a Sync NI writer with a previous background of working in FinTech and financial crime. She has a special interest in sports and emerging technologies. To connect with Niamh, feel free to send her an email or connect on Twitter.

    Got a news-related tip you’d like to see covered on Sync NI? Email the editorial team for our consideration.

Share this story